Polmacoxib
- Generic Name
- Polmacoxib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H16FNO4S
- CAS Number
- 301692-76-2
- Unique Ingredient Identifier
- IJ34D6YPAO
- Background
Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Localized Primary Osteoarthritis of Hip, and Localized Primary Osteoarthritis of Knee.
- Associated Conditions
- -
- Associated Therapies
- -
Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT05370716
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT03775629
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath